Document is current
Any future updates will be listed below
-
Authors
Li, Yong
Zhou, Aiping
Liu, Shuoyan
He, Ming
Chen, Keneng
Tian, Ziqiang
Li, Yin
Qin, Jianjun
Wang, Zhen
Chen, Haiquan
Tian, Hui
Yu, Yue
Qu, Wang
Xue, Liyan
He, Shun
Wang, Shuhang
Bie, Fenglong
Bai, Guangyu
Zhou, Bolun
Yang, Zhaoyang
Huang, Huiyao
Fang, Yan
Li, Benjamin
Dai, Xiangrong
Gao, Shugeng http://orcid.org/0000-0003-4211-552X
He, Jie
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2021YFC2500900)
National Natural Science Foundation of China (82273129)
Medical and Health Science-Technology Innovation Project of the Chinese Academy of Medical Sciences (2021-I2M-1-015)
Central Health Research Key Projects (2022ZD17)
Research Project of the Institute (LC2019L01)
Beijing Natural Science Foundation (7222153)
- License Information
-
More Information
Article History
Received: 26 October 2022
Accepted: 22 February 2023
First Online: 8 March 2023
Declarations
:
: Our research was approved by the ethics committee of all participating institutes (registration number NCT04460066 on clinicaltrials.gov), including the Cancer Hospital Chinese Academy of Medical Sciences. All patients provided written informed consent prior to enrollment in the study.
: All authors agree to the publication of this article.
: Benjamin Li and Xiangrong Dai are from Lee's Pharmaceutical Limited.No other potential conflicts of interest were reported.
